World-Class Leadership


Dr. Olga Kubassova, PhD
Chief Executive Officer
Life Science Innovator, Venture Partner and Bio-Pharma Drug Development Strategist

Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Jan Lundberg_TB Alliance Board of Directors
Dr. Jan Lundberg, MD, PhD
Chair of Scientifc Advisory Board
Novel Drug Discovery and Development

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

Christophe Berthoux, MD
Biotech and Pharma Drug Development Strategy

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

Michael Clark, PMP
Chief Operating Officer
Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

Jon Himoff
Chief Product Officer
Leading Product Design and Engineering organization with P&L ownership and customer focus.

IAG’s CPO and technology leader with 20+ years of experience developing products and scaling companies globally.